Scientists devise method for faster detection of rare leukemia

10/6/2008 | FDAnews · Yahoo!

U.S. researchers have developed a technique to detect juvenile myelomonocytic leukemia -- a rare type of the disease -- within a few hours rather than weeks. The method, which is based on flow cytometry, uses fluorescent-tagged antibodies to identify and organize cells that have the STAT5 protein in patients with the disease. The approach may prove useful in evaluating the efficacy of potential drug therapies against JMML and other conditions, researchers said.

View Full Article in:

FDAnews · Yahoo!

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC